PKCα mediates acetylcholine-induced activation of TRPV4-dependent calcium influx in endothelial cells

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H757-65. doi: 10.1152/ajpheart.00142.2011. Epub 2011 Jun 24.

Abstract

Transient receptor potential vanilloid channel 4 (TRPV4) is a polymodally activated nonselective cationic channel implicated in the regulation of vasodilation and hypertension. We and others have recently shown that cyclic stretch and shear stress activate TRPV4-mediated calcium influx in endothelial cells (EC). In addition to the mechanical forces, acetylcholine (ACh) was shown to activate TRPV4-mediated calcium influx in endothelial cells, which is important for nitric oxide-dependent vasodilation. However, the molecular mechanism through which ACh activates TRPV4 is not known. Here, we show that ACh-induced calcium influx and endothelial nitric oxide synthase (eNOS) phosphorylation but not calcium release from intracellular stores is inhibited by a specific TRPV4 antagonist, AB-159908. Importantly, activation of store-operated calcium influx was not altered in the TRPV4 null EC, suggesting that TRPV4-dependent calcium influx is mediated through a receptor-operated pathway. Furthermore, we found that ACh treatment activated protein kinase C (PKC) α, and inhibition of PKCα activity by the specific inhibitor Go-6976, or expression of a kinase-dead mutant of PKCα but not PKCε or downregulation of PKCα expression by chronic 12-O-tetradecanoylphorbol-13-acetate treatment, completely abolished ACh-induced calcium influx. Finally, we found that ACh-induced vasodilation was inhibited by the PKCα inhibitor Go-6976 in small mesenteric arteries from wild-type mice, but not in TRPV4 null mice. Taken together, these findings demonstrate, for the first time, that a specific isoform of PKC, PKCα, mediates agonist-induced receptor-mediated TRPV4 activation in endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology*
  • Animals
  • Calcium Signaling / drug effects*
  • Carbazoles / pharmacology
  • Cells, Cultured
  • Endothelial Cells / drug effects*
  • Endothelial Cells / enzymology
  • Enzyme Activation
  • Male
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / enzymology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mutation
  • Nitric Oxide Synthase Type III / metabolism
  • Phosphorylation
  • Protein Kinase C-alpha / genetics
  • Protein Kinase C-alpha / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • TRPV Cation Channels / agonists*
  • TRPV Cation Channels / deficiency
  • TRPV Cation Channels / genetics
  • TRPV Cation Channels / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology
  • Time Factors
  • Transfection
  • Vasodilation / drug effects*
  • Vasodilator Agents / pharmacology*

Substances

  • Carbazoles
  • Protein Kinase Inhibitors
  • TRPV Cation Channels
  • Trpv4 protein, mouse
  • Vasodilator Agents
  • Go 6976
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse
  • Prkca protein, mouse
  • Protein Kinase C-alpha
  • Acetylcholine
  • Tetradecanoylphorbol Acetate